| Literature DB >> 29144410 |
Zhenghong Gao1,2, Noémie Danné3,4, Antoine Guillaume Godin5,6, Brahim Lounis7,8, Laurent Cognet9,10.
Abstract
Fluorescence imaging of biological systems down to the single-molecule level has generated many advances in cellular biology. For applications within intact tissue, single-walled carbon nanotubes (SWCNTs) are emerging as distinctive single-molecule nanoprobes, due to their near-infrared photoluminescence properties. For this, SWCNT surfaces must be coated using adequate molecular moieties. Yet, the choice of the suspension agent is critical since it influences both the chemical and emission properties of the SWCNTs within their environment. Here, we compare the most commonly used surface coatings for encapsulating photoluminescent SWCNTs in the context of bio-imaging applications. To be applied as single-molecule nanoprobes, encapsulated nanotubes should display low cytotoxicity, and minimal unspecific interactions with cells while still being highly luminescent so as to be imaged and tracked down to the single nanotube level for long periods of time. We tested the cell proliferation and cellular viability of each surface coating and evaluated the impact of the biocompatible surface coatings on nanotube photoluminescence brightness. Our study establishes that phospholipid-polyethylene glycol-coated carbon nanotube is the best current choice for single nanotube tracking experiments in live biological samples.Entities:
Keywords: bio-imaging; encapsulation; photoluminescence; single particle tracking; single-walled carbon nanotube
Year: 2017 PMID: 29144410 PMCID: PMC5707610 DOI: 10.3390/nano7110393
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Some known biological effects of nanotubes encapsulated with the coating used in this study.
| Nanotubes | Surfactant | Biological System | Dose | Exposure Time | Assay Method | Conclusion | Reference |
|---|---|---|---|---|---|---|---|
| HiPco SWCNTs | PLPEG | Human serum and intravenous injection in rats | 60 μg/mL | 0.5 h | ELISA | Activation of the complement system by SWCNTs in undiluted normal human serum and in vivo rats. | [ |
| HiPco SWCNTs | PLPEG | Intravenous/brain injection in rats | 60 μg/mL | 0.5 h to days | Fluorescence | In vivo SWCNT circulation (vascular system, brain). Stable imaging in vivo and in tissues. | [ |
| HiPco SWCNTs | Pluronic F108 | J774.1A mouse peritoneal macrophage | 11 ng/mL | 0, 8, 18 and 24 h | Fluorescence | Macrophages can ingest significant quantities of SWCNTs without showing toxic effects. Stable imaging in cells. | [ |
| HiPco SWCNTs | Pluoronic F127 | HeLa cells | 200 μg/mL | 2 days | Fluorescence imaging | Induction of actin bundling in cells, reduced cellular proliferation. | [ |
| Arc Discharge SWCNTs | Tween20 | Pathgen free guinea pigs | 50 mg/mL | 4 weeks | Lung function, bronchoalveolart lavega | No abnormalities of pulmonary function or measurable inflammation in guinea pigs. | [ |
| MWCNTs | Sterile saline + Brij 35 | Incubation with cytochrome P450 enzymes (CYP3A4) | 0.067 mg/mL | 5 min at 37 °C | Capillary electrochromatography, enzyme activity monitoring | No effect on CYP3A4 activity. Substantial improvement of migration time and peak shape repeatability in capillary electrochromatography. | [ |
| HiPco SWCNTs | ISPVP | Human embryonic kidney cells (HEK cells) | 1/30 μg/mL | 5 min at RT or 12 h at 37 °C | Fluorescence | Stable imaging in cells. | [ |
HiPco: High-Pressure carbon monoxide; SWCNTs: Single-walled Carbon Nanotubes; MWCNTs: Multi-walled Carbon Nanotubes; PLPEG: Phospholipid-polyethylene Glycol; ISPVP: In Situ Polymerized (poly)vinyl pyrrolidone.
Figure 1Live cell biocompatibility of SWCNTs encapsulated with different coatings. Top (a): Bright-field images of COS-7 incubated with PLPEG-, F108-, Tween20-, Brij35-, and ISPVP-coated SWCNTs for one day and four days. Scale bar: 30 µm. Bottom: Corresponding comparisons of cellular (b) proliferation and (c) viability. Starting concentration of COS-7 cells: 1 × 105 cells/mL, SWCNT: 1 μg/mL, cell cultured at 37 °C with 5% CO2; Three independent experiments were performed to obtain standard variations. Cell viability was evaluated using trypan blue dye staining.
Figure 2SWCNT interactions with live cells probed by NIR photoluminescence. (a) Bright-field and NIR photoluminescence imaging (inserts) of live cells incubated for 24 h with Tween20-, F108-, or PLPEG-coated SWCNTs and further rinsed before imaging. PLPEG- and F108-coated SWCNTs displayed lower non-specific interactions with live cells compared to Tween20-coated SWCNTs. Scale bars: 25 µm for the bright field images and 10 µm for the magnified NIR photoluminescence images of SWCNTs; (b) Corresponding median (red), 25–75th percentile (blue), and 0–100th percentile (black) of the number of SWCNT PL spots observed on live cells for Tween20-, F108- or PLPEG-coated SWCNTs (N = 70, 53, and 86 cells respectively, n.s.: not significant, ** p < 0.01, *** p < 0.001, Kolmogorov-Smirnov test).
Figure 3Photoluminescence imaging of individual SWCNTs. (a) Cumulative distribution of the photoluminescence intensities from 162 (resp. 256) individual PLPEG- (resp. F108-) coated SWCNTs in biological media (DMEM); (b–d) Single PLPEG-SWCNT tracking in 1.5% agarose gels: three frames, separated by 30 s, of a ~1 min movie acquired at 33 Hz are displayed revealing the SWCNT trajectory within the gel; (e) Super-resolved map of the gel structure reconstructed from the collection of 2096 super-localized nanotube positions while the nanotube was diffusing. Scale bar: 5 µm.